#1 Clinical Trials Search in Europe

Metronidazole

Metronidazole, a versatile antibiotic, has been the subject of numerous clinical trials investigating its efficacy in treating various conditions. This article explores the use of metronidazole in different formulations and applications, from bacterial vaginosis to Crohn’s disease, highlighting its potential benefits and effectiveness across multiple medical fields.

Table of Contents

What is Metronidazole?

Metronidazole is an antibiotic medication used to treat various bacterial and parasitic infections. It is known by several brand names, including Flagyl[1]. Metronidazole works by killing or stopping the growth of certain bacteria and parasites that cause infections in your body[2].

Conditions Treated with Metronidazole

Metronidazole is used to treat a wide range of conditions, including:

  • Bacterial vaginosis: An infection of the vagina caused by an overgrowth of certain bacteria[3]
  • Complicated intra-abdominal infections: Infections inside the abdomen, often following surgery or injury[4]
  • Clostridium difficile associated diarrhea (CDAD): A type of diarrhea caused by a specific bacteria, often after taking other antibiotics[5]
  • Helicobacter pylori infection: A bacteria that can cause stomach ulcers[6]
  • Periodontal diseases: Infections of the gums and other structures around the teeth[7]
  • Crohn’s disease: A type of inflammatory bowel disease (in some cases, as part of combination therapy)[8]

Forms and Administration

Metronidazole comes in several forms, including:

  • Oral tablets or capsules[1]
  • Vaginal gel[9]
  • Intravenous (IV) solution for hospital use[4]

The dosage and duration of treatment depend on the specific condition being treated and can vary from a single dose to several weeks of treatment[2][5].

How Metronidazole Works

Metronidazole belongs to a class of drugs called nitroimidazoles. It works by entering the cells of bacteria and parasites. Once inside, it is converted into compounds that damage the genetic material (DNA) of the microorganisms. This prevents them from making new DNA and ultimately leads to their death[2].

Effectiveness of Metronidazole

Clinical trials have shown that metronidazole is effective for treating various infections:

  • For bacterial vaginosis, metronidazole vaginal gel has been shown to be effective in curing the infection in many women[3].
  • In complicated intra-abdominal infections, metronidazole (when combined with other antibiotics) has demonstrated high cure rates[4].
  • For Helicobacter pylori infections, metronidazole is often part of a combination therapy that has shown good eradication rates[6].
  • In treating Clostridium difficile associated diarrhea, metronidazole has been a standard treatment, although newer options are also being studied[5].

Possible Side Effects

Like all medications, metronidazole can cause side effects. Common side effects may include:

  • Nausea
  • Diarrhea
  • Metallic taste in the mouth
  • Headache

More serious side effects are rare but can occur. It’s important to discuss potential side effects with your healthcare provider[2][5].

Ongoing Research

Researchers continue to study metronidazole to understand its effects better and explore new uses:

  • Studies are looking at different formulations of metronidazole, such as delayed-release forms, which may increase the concentration of the antibiotic in the colon for treating certain infections[5].
  • Researchers are investigating the use of metronidazole in combination with other antibiotics for treating conditions like Crohn’s disease in children[8].
  • Scientists are also studying how metronidazole affects the body’s iron levels, which could have implications for its long-term use[6].
Aspect Details
Formulations Studied Vaginal gel, oral capsules, intravenous injections, intralesional injections
Conditions Investigated Bacterial vaginosis, C. difficile colitis, Crohn’s disease, post-operative infections, cutaneous leishmaniasis
Key Study Types Bioequivalence studies, efficacy trials, combination therapy investigations
Novel Approaches Delayed-release formulations, combination with other antibiotics (e.g., azithromycin)
Primary Outcomes Measured Cure rates, pharmacokinetics, reduction in symptoms, prevention of infections
Patient Populations Adults, children with Crohn’s disease, women undergoing hysterectomy
Administration Routes Oral, vaginal, intravenous, intralesional

FAQ

  • What conditions is metronidazole being studied for in clinical trials? Metronidazole is being studied for various conditions including bacterial vaginosis, Clostridium difficile associated diarrhea, Crohn's disease, post-operative infections after hysterectomy, and cutaneous leishmaniasis.
  • How is metronidazole administered in these trials? Metronidazole is administered in various forms depending on the condition being treated. It can be given as a vaginal gel, oral capsules, intravenous injections, and even as an intralesional injection for cutaneous leishmaniasis.
  • What is bioequivalence and why is it important in metronidazole trials? Bioequivalence refers to the comparison of different formulations of a drug to ensure they have the same biological effects. It's important in metronidazole trials to ensure that generic versions or new formulations are as effective as established brand-name versions.
  • Are there any new formulations of metronidazole being tested? Yes, some trials are testing modified release formulations of metronidazole, such as delayed-release forms designed to release the drug just before the colon to potentially improve effectiveness in treating C. difficile colitis.
  • How is metronidazole being used in combination with other treatments? In some trials, metronidazole is being used in combination with other antibiotics. For example, one study is investigating the combination of azithromycin and metronidazole for treating pediatric Crohn's disease.

Ongoing Clinical Trials on Metronidazole

  • Study on Post-Surgery Antibiotic Use in Patients with Complicated Acute Appendicitis: Evaluating Metronidazole, Ceftriaxone, and Ofloxacin Hydrochloride

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study Comparing Mepacrine and Metronidazole for Treating Resistant Giardiasis in Children Aged 1 to 18 Years

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effects of Metronidazole Cream Removal on Skin Absorption in Healthy Volunteers

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria

  • Study on the Effects of Fecal Microbiome and Fecal Microbiome Filtrate Capsules for Patients with Active Ulcerative Colitis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

Glossary

  • Bioequivalence: A measure of the similarity between different formulations of a drug in terms of their biological effects and availability in the body.
  • Bacterial Vaginosis: A common vaginal infection caused by an imbalance of naturally occurring bacteria in the vagina.
  • Clostridium Difficile Associated Diarrhea (CDAD): A type of diarrhea caused by the bacteria Clostridium difficile, often occurring after antibiotic use.
  • Crohn's Disease: A type of inflammatory bowel disease that causes inflammation of the digestive tract, leading to abdominal pain, severe diarrhea, and other symptoms.
  • Cutaneous Leishmaniasis: A skin infection caused by a parasite transmitted by the bite of certain types of sand flies.
  • Intralesional Injection: A method of administering medication directly into a lesion or affected area of the skin.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Bioavailability: The proportion of a drug that enters the circulation when introduced into the body and is able to have an active effect.
  • Delayed Release: A drug formulation designed to release the active ingredient at a time or location different from immediately after administration.
  • Surgical Site Infection (SSI): An infection that occurs after surgery in the part of the body where the surgery took place.

References

  1. https://clinicaltrials.gov/study/NCT01380522
  2. https://clinicaltrials.gov/study/NCT01380509
  3. https://clinicaltrials.gov/study/NCT01020396
  4. https://clinicaltrials.gov/study/NCT04927312
  5. https://clinicaltrials.gov/study/NCT01559545
  6. https://clinicaltrials.gov/study/NCT03146325
  7. https://clinicaltrials.gov/study/NCT01318928
  8. https://clinicaltrials.gov/study/NCT01596894
  9. https://clinicaltrials.gov/study/NCT01020877